Cargando…
Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study
This was a prospective, longitudinal, multicenter, single-arm controlled trial, using independent core laboratory validation of MRI results, to establish the effectiveness and confirm the safety of the VizAblate® System in the treatment of symptomatic uterine fibroids. The VizAblate System is a tran...
Autores principales: | Bongers, Marlies, Brölmann, Hans, Gupta, Janesh, Garza-Leal, José Gerardo, Toub, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349947/ https://www.ncbi.nlm.nih.gov/pubmed/25774122 http://dx.doi.org/10.1007/s10397-014-0873-1 |
Ejemplares similares
-
The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids
por: Brölmann, Hans, et al.
Publicado: (2015) -
VizAbility
por: Woolsey Kristina Hooper
Publicado: (1996) -
A New Paradigm for Uterine Fibroid Treatment: Transcervical, Intrauterine Sonography-Guided Radiofrequency Ablation of Uterine Fibroids with the Sonata System
por: Toub, David B.
Publicado: (2017) -
The INTEGRITY Trial: Preservation of Uterine-Wall Integrity 12 Months After Transcervical Fibroid Ablation with the Sonata System
por: Bongers, Marlies, et al.
Publicado: (2019) -
Term Delivery in an Infertile Patient after Transcervical Radiofrequency Fibroid Ablation and Assisted Reproductive Technology
por: Pschadka, Gregor, et al.
Publicado: (2019)